| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dce9e29aa36a5ca8aaeeede7e849162e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_21e22312e441618a3409bde19af97273
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5ed9a8826e874e45a3047da75b569965
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3d75a1c9ea15858054279dcff2a3a2dd |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4015
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4891
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5026 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-50 |
| filingDate |
2009-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2013-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f9d2826dbb599f8ef5e76e88afec443
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ffa2c508d8c4618fa0566fd82e5002eb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a1f690e9393fb2fe2f5368183e14025e |
| publicationDate |
2013-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-8460712-B2 |
| titleOfInvention |
Prolonged release formulations comprising an 2-oxo-1-pyrrolidine derivate |
| abstract |
The present invention relates to a pharmaceutical composition comprising Brivaracetam or Seletracetam as active ingredient, the invention relates specifically to a prolonged release formulation made of granules containing the active ingredient in their inner core. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2019142759-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2020085754-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10987324-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10973783-B2 |
| priorityDate |
2008-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |